Amneal has announced the appointment of two new executives to its leadership team, with former Alvotech chief quality officer Reem Malki joining Amneal in the same capacity, at the same time as the US Food and Drug Administration’s former director of the office of generic drug policy, Maryll Toufanian, has been named as Amneal’s head of regulatory strategy and policy. Both have been made senior vice-presidents.
Amneal Takes New Execs From Alvotech And FDA
Malki Joins As Quality Chief While Toufanian Heads Regulatory Strategy And Policy
Amneal has looked to biosimilars developer Alvotech and the US FDA’s Office of Generic Drugs for its latest executive appointments, with Reem Malki joining the US firm as chief quality officer and Maryll Toufanian becoming head of regulatory strategy and policy.
